UPDATES: Medicines Supply Notifications

UPDATES: Medicines Supply Notifications

May 17, 2021

Flixotide® 100mcg Accuhaler and Irbesartan/Hydrochlorothiazide 150mg/12.5mg & 300mg/12.5mg tablets.

Please find attached two Medicine Supply Notifications issued by NHSE&I – East Midlands on behalf of the Department of Health & Social Care’s Medicine Supply Team:

  • A Tier 2 medicine supply notification for Flixotide® (fluticasone propionate) 100 microgram Accuhaler
  • An updated Tier 2 medicine supply notification for Irbesartan/hydrochlorothiazide 150mg/12.5mg and 300mg/12.5mg tablets
Medicine Out of stock until Alternatives
Flixotide® (fluticasone propionate) 100 microgram Accuhaler
  • w/c 31st May 2021
  • Flixotide® 125 microgram Evohaler remain available and able to support a full increase in demand.
  • Flixotide® 50 microgram Evohaler and  Flixotide® 50 microgram/dose Accuhaler are available and able to support a partial increase in demand.
  • Unlicensed imports have also been sourced.

Irbesartan/Hydrochlorothiazide 150mg/12.5mg and 300mg/12.5mg tablets

(Updated MSN)

  • 150mg/ 12.5mg – Early June 2021
  • 300mg/ 12.5mg – Out of stock from mid-May until early June 2021
  • Irbesartan 150mg and 300mg tablets and Bendroflumethiazide 2.5mg tablets are available.

There have also been changes to the resupply dates of the medicines listed below. These communications were previously circulated via the NHSE&I commissioning routes.

Original MSN reference Date of original MSN/SDA Supply issue Resupply date originally communicated Updated resupply date as of w/c 10th May 2021
MSN/2021/016 25/3/2021 Voriconazole 40mg/ml oral suspension Late April 2021 Delayed, TBC
SDA/2021/005 4/3/2021 Repaglinide 1mg and 2mg tablets Early May 2021 Back in stock

Please be aware this communication is also being circulated separately to all community pharmacies in England.

Please note that for supply issues that have been categorised as Tier 1 or 2, DHSC and the MSRG have requested that the NHSE&I commissioning routes are used to reach community pharmacy and GP practices. More serious supply issues are communicated via the Central Alerting System for action.


If you have any queries please contact: DHSCmedicinesupplyteam@dhsc.gov.uk

Please note, if the enquiry relates to any changes (additions or removals) to the mailing list and you are enquiring from a GP practice, please contact the NHSE&I Head of Primary Care commissioning.

Many thanks for your assistance with this important issue.

 



Posted in:


More Latest News >

Health and Wellbeing Support Offer

Presentation detailing the health and wellbeing services available to Community Pharmacists and how to access: LLR Primary Care Staff Health...